Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

GRDX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GridAI Technologies Corp.(GRDX US)

$5.76-0.071.29%Ext:$5.70-0.061.02%(Market Closed · 23:59:36 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

GridAI Technologies Corp. — Company Profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Sector
Health Care
Industry
Pharmaceuticals
Exchange
UQ
CEO
Jason David Sawyer
Headquarters
Edinburgh, FL, GB
IPO Date
Oct 11, 2016
Employees
2
Website
www.grid-ai.com

Key Metrics

Price
$3.74
Market Cap
$26.67M
Revenue (TTM)
$85.88K
Net Income (TTM)
$-221221.00
EPS (TTM)
-2.01
P/E (TTM)
-3.37
P/B (TTM)
1.79
Dividend Yield
0.00%
ROE (TTM)
-1.49%
ROA (TTM)
-0.60%
Operating Margin
-152.62%
Beta
1.09

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Website
www.grid-ai.com
Location
Edinburgh, FL, GB
Phone(561) 589-7020
Employees2
CEOJason David Sawyer
Sector
Health Care
Industry
Pharmaceuticals
IPO DateOct 11, 2016

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(736)

Expand
  • 4Uppal Manpreet28 Oct
  • 4Syage Jack28 Oct
  • 4Skowron Anna28 Oct
  • 4Sawyer Jason David28 Oct
  • 4Pursglove Geordan Garrett28 Oct
  • 4BORKOWSKI EDWARD28 Oct
  • 8-KEntry into a Material Definitive Agreement28 Oct
  • 8-KEntry into a Material Definitive Agreement28 Oct
  • POS AMPost-effective amendment (unspecified)28 Oct
  • S-8Registration statement (employee benefit plan)26 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers23 Oct
  • EFFECTNotice of effectiveness20 Oct
  • 424B3Prospectus filing (Rule 424(b)(3))19 Oct
  • 4Sawyer Jason David9 Oct
  • 8-KEntry into a Material Definitive Agreement7 Oct
  • S-1/ARegistration statement (general form, amendment)6 Oct
  • 10-Q/AQ2ended 30 Jun 202617 Sep
  • 8-KEntry into a Material Definitive Agreement11 Sep
  • S-1/ARegistration statement (general form, amendment)24 Aug
  • 10-QQ2ended 30 Jun 202621 Aug

Mentions in Filings

  • … ection with commercial real estate and related business transactions, qualifies him to serve as a director. ***Manpreet Uppal age 40.*** Manpreet (Mike) Uppal has served as a member of the Board of Directors of <strong>GridAI Technologies Corp.</strong> (Nasdaq: GRDX) (formerly Entero Therapeutics, Inc.) since February 2025, serving on the Audit Committee (as financial expert), Compensation Committee, and Nominating and Corporate Governance Committee. In this ro …
    GeoVax Labs, Inc.GridAI Technologies Corp.·8-K - Entry into a Material Definitive Agreement·Q4 26·27 Oct
  • … audit committee member of Mixed Martial Arts Group Limited (NYSE American: MMA). From February 2025 to September 2025, he served as Interim Chief Executive Officer and Chairman of Entero Therapeutics, Inc., now <strong>GridAI Technologies Corp.</strong>, and from September 2024 to June 2025 as a director of iSpecimen Inc., including as Chairman from February 2025. He also serves on the boards of public companies in Canada and the United Kingdom, including Ashing …
    Hub Cyber Security Ltd.GridAI Technologies Corp.·EX-99.1 - 6-K - PRESS RELEASE DATED OCTOBER 13, 2026·Q4 26·13 Oct
  • … hairman of 8 Prime Biosciences, a private company. Prior to that, from October 2019 to February 2025, Mr. Sapirstein as Chief Executive Officer and Chairman of Entero Therapeutics, Inc. (Nasdaq: ENTO) (now known as <strong>GridAI Technologies</strong> Corp., Nasdaq:GRDX) and as a consultant from February 2025 to March 2026. His career includes senior roles at Gilead Sciences, Bristol Myers Squibb, Hoffmann-La Roche, Eli Lilly and Serono Laboratories. Mr. Sapirste …
    Inmune Bio, Inc.GridAI Technologies Corp.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·14 Sep
  • … c and private companies, including financial reporting, SEC compliance, corporate governance, internal controls, capital markets and mergers and acquisitions. Ms. Skowron has served as Chief Financial Officer of <strong>GridAI Technologies Corp.</strong> (Nasdaq: GRDX) since March 2025 and as Chief Financial Officer of Powell Max Limited (Nasdaq: PMAX) since January 2026. Since September 2025, Ms. Skowron has served as Principal of BPC Consulting Ltd., a financia …
    BioRestorative Therapies, Inc.GridAI Technologies Corp.·8-K - Changes in Registrant's Certifying Accountant·Q3 26·1 Sep
  • … hedge funds. He has also co-founded and financed ventures such as Pacific West Stone, California Fitness, Sanna Health Corp., and Caary Capital. Mr. Sawyer currently serves as CEO and a Director on the Board of <strong>GridAI Technologies Corp.</strong> (Nasdaq: GRDX), and in an advisory role as Head of Finance and M&A at Quantum BioPharma (Nasdaq: QNTM). He is a Director on the Board of The FUTR Corp. (TSX.V: FTRC), serves as a Director on the Board of Lixte Bi …
    Greenland Mines LtdGridAI Technologies Corp.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q2 26·22 Apr

Key Stats

Trading

Px/Chg 1D$3.74 / -1.84%
Avg Volume117.38K
Beta1.09
Mkt Cap26.67M
FD Mkt Cap12.78M

Float

Shrs Out/Float7.13M / 6.08M
Short Float0.01%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV35.78M
EV/EBITDA-1.72
EV/Sales223.18
P/B1.79
P/S166.34
FCF Yield-5.64%
ROE-1.49%
ROA-0.60%
Current Ratio0.16

Estimates

P/E-3.37
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-24.80-0.42-0.19-0.32-2.50-120.56
Price / Sales103.230.000.000.00205.59310.57
Price / Book Value1.062.260.840.100.311.79
Price / Free Cash Flow-4.15-0.28-0.23-0.63-1.88-17.72
ENTERPRISE VALUE METRICS
Enterprise Value25.45.70.167.517.835.8
Enterprise Value / Sales181.730.000.000.00491.95416.70
Enterprise Value / EBITDA-2.36-0.39-0.01-4.33-4.34-2.73
Enterprise Value / EBIT-1.70-0.39-0.01-4.32-3.800.00

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue—----0.0
Gross Income23.1%-0.5-0.1-0.0-0.0-1.2
EBITDA-42.1%-58.0-14.6-15.7-15.6-6.5
EBIT-41%-58.5-14.6-15.8-15.6-7.1
Net Income-42.2%-58.5-14.6-15.8-18.1-6.6
EPS (Diluted)-88.9%-27,544.98-407.37-46.96-5.33-4.16
BALANCE SHEET
Cash & ST Inv-42.5%8.21.43.70.20.9
Total Assets43.1%11.85.46.985.449.5
Total Liabilities13.6%19.62.73.327.619.7
Total Shareholder Equity—-7.82.73.657.823.7
CASH FLOW
Net Operating Cash Flow-35.2%-32.3-22.3-12.4-9.2-5.7
Cap Ex—-10.3--0.5-0.0
Free Cash Flow-39.5%-42.6-22.3-12.9-9.2-5.7

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)5.52
Basic Shares7.13
Market Cap39.4
Diluted Shares6.42
Fully Diluted Shares Outstanding6.42
Fully Diluted Market Cap35.4
+Consolidated Debt1.8
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-1.4
−Short-term Investments-
+Total Preferred3.9
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest4.8
+Pension Liabilities—
Enterprise Value48.5

Related companies

NextEra Energy Inc.

NEE US

China Yangtze Power Co., Ltd.

600900 CG

Enel SpA

ENLAY US

Southern Co

SO US

Constellation Energy Corp

CEG US

Duke Energy CORP

DUK US

Engie S.A.

ENGIY US

American Electric Power Co Inc

AEP US

Rwe Ag /FI

RWEOY US

Vistra Corp.

VST US

Xcel Energy Inc

XEL US

Exelon Corp

EXC US